Global licensing - out

Search documents
药明康德:盈利回顾 - 将 2025 财年持续运营业务指引上调至同比增长 13 - 17%,TIDES 业务预计同比增长 80%-WuXi AppTec Co. (2359.HK)_ Earnings review_ Raised FY25 guidance to +13-17% y_y for continuing operation, with TIDES to grow by 80% yy
2025-08-05 03:20
30 July 2025 | 12:07AM HKT WuXi AppTec Co. (2359.HK): Earnings review: Raised FY25 guidance to +13-17% y/y for continuing operation, with TIDES to grow by 80% y/y We see the 2Q25 results as a strong delivery (see our note on profit alert), 2Q25 sales of Rmb11.1bn (+20.4% y/y) primarily driven by faster-than-expected capacity validation, utilization ramp-up, and strong operational execution, where management noted no significant changes in client behavior related to front-loading ahead of tariff risks - cons ...